BDSX — BIODESIX INC
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1439725 ·
Last close
$15.06
Market Cap
$155.96M
52W High
$20.20
52W Low
$9.43
ADV30
65,657
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 25,555,000 | 21,350,000 | -6,196,000 | -7,793,000 | 94,637,000 | 25,572,000 | 85,505,000 |
| Dec 2025 | 28,755,000 | 23,876,000 | -1,966,000 | -3,980,000 | 87,476,000 | 18,987,000 | 89,941,000 |
| Sep 2025 | 21,768,000 | 17,662,000 | -7,044,000 | -8,716,000 | 88,722,000 | 16,604,000 | 90,444,000 |
| Jun 2025 | 20,018,000 | 15,987,000 | -9,693,000 | -11,468,000 | 87,740,000 | 20,728,000 | 86,602,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-24,837,000
Investing CF
$-410,000
Financing CF
$33,217,000
CapEx
$-410,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.06
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-505,555,000
Inventory
—
Receivables
$9,500,000
ST Investments
—
EBIT TTM
$-23,949,000
Pretax Income TTM
$-31,957,000
Interest Exp TTM
$8,008,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$96,096,000
EBITDA
$-19,673,000
Free Cash Flow
$-13,779,875
Enterprise Value
$200,231,216
Total Cash
$25,572,000
Total Debt
$73,568,000
Shares Out
10,355,809
Trailing EPS
$-3.96
Book Value
$0.90
ROE
-316.5%
ROA
-17.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 88,499,000 | -27,766,000 | -35,265,000 | 87,476,000 | 89,941,000 | — | -23,271,000 |
| Dec 2024 | 71,323,000 | -34,260,000 | -42,931,000 | 97,244,000 | 76,368,000 | — | -48,649,000 |
| Dec 2023 | 49,087,000 | -41,298,000 | -52,146,000 | 99,096,000 | 94,516,000 | — | -22,870,000 |
| Dec 2022 | 38,212,000 | -50,506,000 | -65,447,000 | 92,906,000 | 72,300,000 | — | -44,972,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.22
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AUNA | AUNA S.A. | $148.58M | $4.93 | — |
| ALPS | Alps Group Inc | $120.64M | $0.73 | — |
| XGN | EXAGEN INC. | $112.83M | $4.67 | — |
| LFMD | LifeMD, Inc. | $227.30M | $4.70 | — |
| YDES | YD Bio Ltd | $231.62M | $3.27 | — |
News headlines (Yahoo Finance, 1h cache)
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
2026-06-15 13:40 · Yahoo
Zacks Industry Outlook Highlights BrightSpring Health Services, Biodesix and HealthEquity
2026-06-09 11:16 · Yahoo
3 Medical Service Industry Stocks Thriving Amid Workforce Challenges
2026-06-08 12:22 · Yahoo
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
2026-05-28 13:40 · Yahoo
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade
2026-05-25 13:55 · Yahoo
Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions
2026-05-23 12:16 · Yahoo
Biodesix to Participate in Upcoming Investor Conferences
2026-05-21 10:00 · Yahoo
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
2026-05-12 13:40 · Yahoo
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
2026-05-11 13:17 · Yahoo
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?
2026-05-07 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.